Trials / Recruiting
RecruitingNCT06693700
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Conditions
- Smoking
- Smoking Cessation
- Smoking Reduction
- Smoking Habit
- Smoking Behaviors
- Smoking, Tobacco
- Smoking, Cigarette
- Smoking (Tobacco) Addiction
- Tobacco Use
- Tobacco Smoking
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Indoor Air Quality Monitor AirGradient ONE | Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs. |
Timeline
- Start date
- 2024-11-14
- Primary completion
- 2027-11-14
- Completion
- 2027-11-14
- First posted
- 2024-11-18
- Last updated
- 2025-10-22
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06693700. Inclusion in this directory is not an endorsement.